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Background-—Smoking is an overwhelming, but preventable, risk factor for cardiovascular diseases (CVD), although smoking
prevalence remains high in developed and developing countries in East Asia.
Methods and Results-—In a population-based sample of 1019 Japanese men aged 40 to 79 years, without CVD, we examined cross-
sectional associations of smoking status, cumulative pack-years, daily consumption, and time since cessation, with subclinical
atherosclerosis at 4 anatomically distinct vascular beds, including coronary artery calciﬁcation, carotid intima-media thickness (CIMT)
and plaque, aortic artery calciﬁcation (AoAC), and ankle-brachial index. Current, former, and never smoking were present in 32.3%,
50.0%, and17.7%, respectively. Compared tonever smokers, current smokers hadsigniﬁcantly higher risks of subclinical atherosclerosis
in all 4 circulations (eg, odds ratios for coronary artery calciﬁcation >0, 1.79 [95% CIs, 1.16–2.79]; CIMT >1.0 mm, 1.88 [1.02–3.47];
AoAC >0, 4.29 [2.30–7.97]; and ankle-brachial index <1.1, 1.78 [1.16–2.74]) and former smokers did in carotid and aortic circulations
(CIMT>1.0 mm, 1.94 [1.13–3.34]; and AoAC >0, 2.55 [1.45–4.49]). Dose–response relationships of pack-years and daily consumption,
particularlywithCIMT, carotid plaque, AoAC, and ankle-brachial index,were observed amongboth current and former smokers, and even
a small amount of pack-years or daily consumption among current smokers was associated with coronary artery calciﬁcation and AoAC,
whereas time since cessation among former smokers was linearly associated with lower burdens of all atherosclerotic indices.
Conclusions-—Cigarette smoking was strongly associated with subclinical atherosclerosis in multiple vascular beds in Japanese
men, and these associations attenuated with time since cessation. ( J Am Heart Assoc. 2016;5:e003738 doi: 10.1161/
JAHA.116.003738)
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S moking remains the number 1 preventable cause of deathworldwide, and it contributes signiﬁcantly to cardiovas-
cular diseases (CVD).1 Despite a recent decline in smoking
rates in Western industrialized countries, tobacco use is still
very high in developing Asian countries as well as in
industrialized ones, including Japan, with 30% of the male
population lighting up.1 Among many contributors for CVD,
smoking is one of the leading avoidable causes, and therefore
advancing a tobacco-free world is a key strategic priority in
preventive medicine.
The evidence linking smoking exposure with various CVD,
including myocardial infarction, stroke, and aortic and
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peripheral vascular diseases, is clearly present, although the
mechanisms accounting for these associations have not been
fully elucidated.2 Atherosclerosis is considered to be a critical
player in the pathophysiology of smoking-induced CVD,2 and
these adverse effects would be reduced by smoking cessa-
tion.3 Accordingly, in the view of public health and clinical
resources, determining which measures of subclinical
atherosclerosis are most inﬂuenced by smoking, and whether
any of the relationship between smoking and these subclinical
measures decrease with longer time since smoking cessation
is of utmost importance.
Precise and valid measures of subclinical atherosclerosis
are available for coronary, carotid, aortic, and peripheral
circulations; however, few population-based studies have
assessed the associations of both smoking and smoking
cessation with subclinical atherosclerosis,4,5 and no studies,
to date, have examined the association of smoking and
smoking cessation with subclinical atherosclerosis in all 4
circulations.
In a general sample of Japanese men with a high smoking
burden, but low atherosclerotic risk,6–8 we aimed to cross-
sectionally investigate the inﬂuence of smoking on these 4
anatomically distinct vascular beds, using coronary artery
calciﬁcation (CAC), carotid intima-media thickness (CIMT) and
plaque, aortic artery calciﬁcation (AoAC), and ankle-brachial
index (ABI), by examining the following: (1) the strength of
association between smoking status and each vascular bed;
(2) whether there are dose-response relationships with
cumulative smoking exposure by pack-years and with smok-
ing intensity by daily cigarette consumption in these associ-
ations; and (3) whether these associations attenuate with
length of time since smoking cessation in former smokers.
Methods
Study Participants and Measurements
The Shiga Epidemiological Study of Subclinical Atherosclero-
sis (SESSA) is an ongoing prospective, population-based study
of a random sample from a general Japanese population as
described elsewhere.9,10 Participants eligible for the present
study were 1094 men aged 40 to 79 years enrolled at
baseline (May 2006–March 2008) in the SESSA. After
excluding 75 participants with a history of myocardial
infarction or stroke (n=66) and with missing information
(n=9), including variables related to smoking, a total of 1019
participants were analyzed in the present study. Of the 1019
participants, 987 underwent carotid ultrasound examination
to assess CIMT and plaque. The present study was approved
by the Institutional Review Board of Shiga University of
Medical Science (No. 17–19, 17–83; Otsu, Japan), and all
participants provided written informed consent.
A self-administered questionnaire was used to obtain
information on demography, smoking habits, alcohol drinking,
physical activity, socioeconomic status, medication use
(hypertension, dyslipidemia, and diabetes mellitus), and
medical history. After the participants completed the ques-
tionnaires, trained nurses conﬁrmed them with the partic-
ipants. Smoking status was categorized into 3 groups:
current, former, and never smokers. Participants who smoked
in the last 30 days were deﬁned as current smokers, whereas
participants who had never smoked before were deﬁned as
never smokers. Based on the information, daily cigarette
consumption was calculated in former and current smokers.
Pack-years were estimated by multiplying the average number
of packs smoked daily by the number of smoking years. Time
since smoking cessation was calculated by subtracting age at
cessation from age at the baseline survey.
Body mass index (BMI) was calculated as weight (kg)
divided by height squared (m2). Using an automated sphyg-
momanometer (BP-8800; Omron Health Care Co. Ltd, Tokyo,
Japan), the mean of 2 consecutive measurements on the right
arm with participants in a seated position after a 5-minute
rest were used to determine blood pressure. Diabetes mellitus
was deﬁned as a hemoglobin A1c ≥6.1% (per the Japan
Diabetes Society protocol; equivalent to ≥6.5% in the National
Glycohemoglobin Standardization Program),11 a fasting blood
glucose ≥126 mg/dL, or the use of antidiabetic medications.
Total cholesterol and triglycerides were measured using
enzymatic assays, and high-density lipoprotein (HDL) choles-
terol (HDL-C) was determined using a direct method. Low-
density lipoprotein cholesterol was estimated using Friede-
wald’s formula12 in the 1003 participants with triglycerides
<400 mg/dL. Lipid measurements were standardized accord-
ing to the protocol for the US Centers for Disease Control and
Prevention/Cholesterol Reference Method Laboratory Net-
work. C-reactive protein (CRP) was measured by nephelom-
etry using a BN II Analyzer with a threshold of 0.16 mg/L.
Alcohol intake was estimated as the total weekly amount of
alcohol consumption (g/week). Participants who exercised
were deﬁned as those who regularly did either brisk walking
or more-active exercise ≥1 h/week.13,14
Assessment of Subclinical Atherosclerosis
We assessed CAC and AoAC either by electron-beam
computed tomography (EBCT) using a C-150 scanner (Ima-
tron, South San Francisco, CA) or 16-channel multidetector-
row computed tomography (MDCT) using an Aquilion scanner
(Toshiba, Tokyo, Japan).9,15 EBCT and MDCT images
accounted for 69.8% and 30.2%, respectively, of coronary
and aortic scans. Images were obtained from the level of the
aortic root through the heart every 3-mm slice to evaluate
CAC and from the aortic arch to the iliac bifurcation every
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6-mm slice to evaluate AoAC, with a scan time of 100 (EBCT)
or 320 ms (MDCT). Presence of CAC and AoAC was deﬁned
as a minimum of 3 contiguous pixels (area=1 mm2) with a
density of ≥130 HU using the AccuImage software (AccuI-
mage Diagnostics, South San Francisco, CA). One trained
physician interpreted coronary and aortic scanning using the
widely accepted Agatston method.16 The physician was
blinded to the participants’ characteristics. Protocols for
CAC and AoAC measurement were developed from a separate
cohort study by our research group,17 in which the repro-
ducibility of coronary and aortic scans was very high
(intraclass correlations of 0.99 and 0.98, respectively).18
Because a stratiﬁed analysis by computed tomography (CT)
type showed similar results, images by EBCT and MDCT were
considered equivalent. Other studies have also reported
comparable ﬁndings for CAC and AoAC assessment by EBCT
and MDCT.19,20
As previously described,10,21 high-resolution B-mode ultra-
sound (Xario-660A; Toshiba Medical Systems, Tokyo, Japan)
was used to scan both right and left carotid arteries with a
7.5-MHz probe according to a standardized method estab-
lished by the Ultrasound Research Laboratory of University of
Pittsburgh (Pittsburgh, PA).22 Images from the following
segments were digitized: both near and far walls of common
carotid arteries (CCA; 1 cm proximal to the carotid bulb); far
wall of the bulb; and far wall of the internal carotid arteries
(ICAs; 1 cm distal to the bulb). Intima-media thickness in each
image was traced with an automatic image-reading program
(AMS; Chalmers University of Technology, Gothenburg, Swe-
den). Mean CIMT comprised the mean of all averages across
the 8 locations (4 in each artery) from CCAs, bulb, and
ICAs.10,21 Carotid plaque was deﬁned as a focal thickening
lesion (≥50% protrusion compared to adjacent areas) with
CIMT >1 mm.21 The total number of plaques in CCAs, bulb,
and ICAs on both left and right sides was counted.
ABI was estimated separately for each leg, with the
numerator being the higher of the dorsalis pedis or posterior
tibial systolic pressures in each leg and the denominator being
the higher of the right versus left brachial systolic pressures,
using an automatic waveform analyzer (Form I PWV/ABI;
Omron Health Care Co. Ltd, Tokyo, Japan), while participants
were in a supine position after a 5-minute rest.10 The select ABI
for participants was the smaller of the right versus left ABI.
Statistical Analysis
Characteristics were analyzed according to smoking status.
Differences in characteristics were evaluated using the
ANOVA, v2 test, or Kruskal–Wallis test. All outcomes were
analyzed in a cross-sectional fashion. For dichotomous
outcomes, including CAC, AoAC, CIMT, and ABI, logistic
regression was used. Cut-off points for CAC were deﬁned as
CAC score >0, ≥100, and ≥400 according to their clinical
signiﬁcance and consistency with previous studies.23,24
Similarly, AoAC was deﬁned as AoAC score >0,
≥100,18,25,26 and ≥1000; CIMT was deﬁned as CIMT
>1.0 mm; and ABI was deﬁned as ABI <1.1.27–29 Because
of the low prevalence of ABI <1.0 (n=44 [4%]), this cut-off
point was not chosen. For carotid plaque, because the
distribution showed overdispersion, negative binomial regres-
sion was used. In all analyses, the adjusted model included
age, BMI, systolic blood pressure, total cholesterol, HDL-C,
medication for hypertension and dyslipidemia (yes/no),
diabetes mellitus (yes/no), alcohol intake (g/week), exercise
(yes/no), and CRP. CT type was further included concomi-
tantly when CAC and AoAC were analyzed. Further adjust-
ment for occupation status and education years did not
substantially affect the ﬁndings, and therefore these variables
were not included in the model. For cumulative exposure or
intensity analyses, the associations of measures of subclinical
atherosclerosis with tertiles of pack-years or daily cigarette
consumption were estimated in both former and current
smokers compared to never smokers. For smoking cessation
analyses, the association of subclinical atherosclerosis with
tertiles of time since cessation was estimated in former
smokers compared to current smokers. Similarly, cessation
analyses were conducted compared to never smokers. As a
sensitivity analysis, daily cigarette consumption was taken
into account in the adjusted model for smoking cessation
analyses. Tertiles were used for pack-years, daily cigarette
consumption, and time since cessation because (1) there are
no established cut-off points for these measures; (2) these
measures were not normally distributed (their distribution
were likely to be right-skewed); and (3) a sufﬁcient sample
size was obtained in each group. Tests for trend across
categories were also based on assigning median value for
each category of pack-years, cigarettes smoked daily, and
years since quitting and modeling this variable as a contin-
uous variable. Analyses were performed using SPSS (version
22.0; SPSS, Inc., Chicago, IL) and SAS software (version 9.4;
SAS Institute Inc., Cary, NC). Two-tailed P values of <0.05
were considered statistically signiﬁcant.
Results
Of the 1019 participants, 329 (32.3%) were current, 509 (50.0%)
were former, and 181 (17.7%) were never smokers. Character-
istics based on smoking status are shown in Table 1. Current
smokers were younger and had lower levels of systolic blood
pressure and HDL-C, a higher level of CRP, less medication for
hypertension, higher alcohol intake, less exercise, and a lower
unemployment rate than former or never smokers.
Compared to never smokers, both former and current
smokers had higher burdens of CIMT (adjusted odds ratio
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[OR] for CIMT >1.0 mm, 1.94; 95% CI, 1.13–3.34, and 1.88;
95% CI, 1.02–3.47, respectively), carotid plaque (adjusted
ratio of expected counts, 1.30; 95% CI, 1.10–1.53, and 1.40;
95% CI, 1.17–1.67, respectively), and AoAC (eg, adjusted OR
for AoAC >0, 2.55; 95% CI, 1.45–4.49, and 4.29; 95% CI,
2.30–7.97, respectively; Table 2). Current smoking, but not
former smoking, was also signiﬁcantly associated with a
higher level of CAC (eg, adjusted OR for CAC ≥400, 2.64; 95%
CI, 1.20–5.79) and lower level of ABI (adjusted OR for ABI
<1.1, 1.78; 95% CI, 1.16–2.74) compared to never smoking
(Table 2).
Graded associations were observed between cumulative
smoking exposure by pack-years and subclinical atheroscle-
rosis, including CIMT, carotid plaque, CAC >0, ABI, and all
indices of AoAC in current smokers (all P for trend <0.05;
Table 2), whereas increases in ORs for CAC ≥100 and ≥400
were not statistically signiﬁcant with higher pack-year
cumulative exposure among current smokers. Similar results
were observed among former smokers (Table S1). Even the
lowest pack-years among current smokers was also signiﬁ-
cantly associated with CAC ≥100, ≥400, and all indices of
AoAC as compared to never smokers (Table 2). Similar
ﬁndings were observed in smoking intensity analyses by daily
cigarette consumption in both current and former smokers
(Table S2).
Compared to current smokers, burdens of subclinical
atherosclerosis in all 4 circulations linearly decreased among
former smokers with length of time since cessation (all P for
trend, <0.05; Table 3). These reductions became signiﬁcant at
≥10.4 cessation years for CAC >0, AoAC >0 and ≥100, and at
≥24.4 cessation years for carotid plaque, CAC ≥100, ≥400,
ABI, and AoAC ≥1000. After further adjustment for daily
cigarette consumption in addition to the adjusted model, the
associations of time since cessation with atherosclerotic
Table 1. Characteristics of Participants According to Smoking Status in 1019 Men Aged 40 to 79 Years (SESSA, Shiga, Japan,
2006–2008)
Smoking Status
Never (n=181) Former (n=509) Current (n=329)
Age, y 63.7 (10.2) 65.4 (9.5) 60.8 (9.7)*†
BMI, kg/m2 23.7 (2.8) 23.5 (3.0) 23.4 (3.1)
Systolic blood pressure, mm Hg 135.4 (17.2) 138.0 (19.7) 134.0 (18.5)†
Diastolic blood pressure, mm Hg 79.8 (9.7) 80.3 (11.3) 78.8 (11.1)
Diabetes mellitus, % 21.0 19.8 23.1
Total cholesterol, mg/dL 207.6 (33.8) 209.3 (32.2) 208.8 (35.4)
High-density lipoprotein cholesterol, mg/dL 59.9 (17.0) 60.2 (17.5) 56.0 (15.7)*†
Low-density lipoprotein cholesterol, mg/dL‡ 125.0 (30.7) 125.5 (29.5) 125.4 (34.6)
Medication for hypertension, % 27.6 33.8 21.6†
Medication for dyslipidemia, % 17.1 13.4 10.0
Alcohol intake, g/week 105.9 (167.1) 165.9 (179.4)§ 196.0 (218.8)*
Exercise, % 45.9 51.5 28.9*†
Occupation status, %
Self-employed including agriculture 12.2 12.0 17.3
Company employees 45.3 41.1 48.3
Unemployed 32.0 38.5 25.8†
Others 10.5 8.4 8.6
Education years, y 12.5 (3.2) 12.5 (3.2) 12.3 (2.9)
CRP, mg/L 0.37 (0.17, 0.65) 0.43 (0.23, 0.90)§ 0.49 (0.25, 1.11)*
Pack-years exposure NA 25.0 (11.3, 42.3) 38.7 (24.3, 51.8)†
Daily cigarettes/day NA 20 (15, 30) 20 (15, 25)
Values are expressed as mean (standard deviation), median (25th, 75th), or percentage. Differences in characteristics were evaluated using the analysis of variance, v2 test, or
Kruskal–Wallis test. BMI indicates body mass index; CRP, C-reactive protein; NA, not applicable; SESSA, Shiga Epidemiological Study of Subclinical Atherosclerosis.
*P<0.01 between never and current smokers.
†
P<0.01 between former and current smokers.
‡
Estimated using Friedewald’s formula in 1003 (never, 179; former, 503; current, 321) men with triglycerides <400 mg/dL.
§
P<0.01 between never and former smokers.
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burdens in all 4 circulations were somewhat attenuated, but
still statistically signiﬁcant except for that with CIMT
(Table S3). Additionally, by 24.4 years for CIMT, carotid
plaque, and AoAC, by 10.4 years for ABI, and even less than
10.4 years for CAC, ORs or ratios of expected counts were
not statistically different for former smokers compared to
never smokers (Table S4).
Discussion
In this community-based, cross-sectional study of Japanese
men without apparent CVD, of which about 30% are current
and 50% are former smokers, signiﬁcant associations were
observed between current smoking and subclinical
atherosclerosis in all 4 vascular beds, including coronary,
carotid, aortic, and peripheral arteries, and between former
smoking and that in carotid and aortic arteries. These
associations, particularly with carotid, aortic, and peripheral
atherosclerosis, also became stronger with increasing cumu-
lative exposure and intensity of smoking in both former and
current smokers compared to never smokers. Even the lowest
amount of pack-years or cigarettes smoked daily among
current smokers was associated with CAC, particularly CAC
≥100 or ≥400, and AoAC. Furthermore, longer time since
smoking cessation was associated with lower degrees of
atherosclerosis in all 4 circulations in former smokers, with
somewhat differences among anatomically distinct sites.
Our results support past demonstrations with respect to
the adverse effect of smoking in multiple vascular beds,
including CAC. McEvoy et al showed that among participants
aged 45–84 years with a smoking rate of 14% and a cessation
rate of 38% in the Multi-Ethnic Study of Atherosclerosis
Table 2. Association of Smoking Status and Cumulative Smoking Exposure by Pack-Years With Measures of Subclinical
Atherosclerosis in Carotid, Coronary, Aortic, and Peripheral Vascular Beds in 1019 Men Aged 40 to 79 Years (SESSA, Shiga, Japan,
2006–2008)
Smoking Status Pack-Years in Current Smokers
Never (n=181) Former (n=509) Current (n=329) <29.1 (n=109) 29.1 to 46.7 (n=110) ≥46.8 (n=110)
P for
Trend
CIMT >1.0 mm, n (%)* 22 (12.6) 105 (21.1) 45 (14.3) 10 (9.6) 12 (11.5) 23 (21.5)
OR 1 (Ref) 1.94 (1.13–3.34)† 1.88 (1.02–3.47)† 1.46 (0.62–3.47) 1.54 (0.67–3.54) 2.47 (1.21–5.05)† 0.024
Carotid plaque,
median (25th, 75th)*
2 (0, 3) 2 (1, 4) 2 (0, 4) 1 (0, 3) 2 (0, 4) 3 (1, 5)
Ratio of expected
counts
1 (Ref) 1.30 (1.10–1.53)‡ 1.40 (1.17–1.67)§ 1.06 (0.84–1.34) 1.45 (1.16–1.80)‡ 1.67 (1.35–2.06)§ <0.001
CAC >0, n (%) 108 (59.7) 332 (65.2) 211 (64.1) 56 (51.4) 73 (66.4) 82 (74.5)
OR 1 (Ref) 1.13 (0.75–1.69) 1.79 (1.16–2.79)‡ 1.30 (0.74–2.29) 2.05 (1.17–3.60)† 2.16 (1.20–3.89)† 0.006
CAC ≥100, n (%) 34 (18.8) 124 (24.4) 81 (24.6) 22 (20.2) 27 (24.5) 32 (29.1)
OR 1 (Ref) 1.33 (0.83–2.13) 2.06 (1.23–3.45)‡ 2.15 (1.09–4.23)† 2.18 (1.14–4.18)† 1.89 (1.01–3.53)† 0.117
CAC ≥400, n (%) 11 (6.1) 46 (9.0) 36 (10.9) 10 (9.2) 11 (10.0) 15 (13.6)
OR 1 (Ref) 1.45 (0.70–3.03) 2.64 (1.20–5.79)† 3.07 (1.14–8.27)† 2.61 (0.98–6.93) 2.43 (0.98–6.01) 0.155
ABI <1.1, n (%) 45 (24.9) 166 (32.6) 120 (36.5) 35 (32.1) 36 (32.7) 49 (44.5)
OR 1 (Ref) 1.36 (0.92–2.03) 1.78 (1.16–2.74)‡ 1.58 (0.91–2.73) 1.53 (0.89–2.65) 2.29 (1.35–3.90)‡ 0.002
AoAC >0, n (%) 132 (72.9) 442 (86.8) 276 (83.9) 80 (73.4) 96 (87.3) 100 (90.9)
OR 1 (Ref) 2.55 (1.45–4.49)‡ 4.29 (2.30–7.97)§ 3.64 (1.69–7.88)‡ 5.21 (2.33–11.64)§ 3.90 (1.61–9.44)‡ <0.001
AoAC ≥100, n (%) 98 (54.1) 348 (68.4) 217 (66.0) 58 (53.2) 73 (66.4) 86 (78.2)
OR 1 (Ref) 1.81 (1.16–2.82)‡ 3.50 (2.10–5.82)§ 2.89 (1.49–5.62)‡ 3.73 (1.99–7.00)§ 3.97 (2.02–7.84)§ <0.001
AoAC ≥1000, n (%) 30 (16.6) 171 (33.6) 103 (31.3) 25 (22.9) 34 (30.9) 44 (40.0)
OR 1 (Ref) 2.61 (1.58–4.30)§ 4.02 (2.31–6.99)§ 3.20 (1.55–6.59)‡ 4.75 (2.40–9.41)§ 4.14 (2.15–7.99)§ <0.001
Pack-years groups were categorized according to tertiles of pack-years in current smokers. All values are expressed as ORs and ratios of expected counts with 95% CIs. For dichotomous
outcomes, logistic regression was used. For carotid plaque, negative binomial regression was used. Adjusted covariates included age, body mass index, systolic blood pressure, total
cholesterol, high-density lipoprotein cholesterol, medication for hypertension and dyslipidemia (yes/no), diabetes mellitus (yes/no), alcohol intake (g/week), exercise (yes/no), and C-
reactive protein. The CT type was further included concomitantly when CAC and AoAC were analyzed. ABI indicates ankle-brachial index; AoAC, aorta artery calciﬁcation; CAC, coronary
artery calciﬁcation; CIMT, carotid intima-media thickness; OR, odds ratio; SESSA, Shiga Epidemiological Study of Subclinical Atherosclerosis.
*A total of 987 (never, 174; former, 498; current, 315 [pack-years <29.1, 104; 29.1–46.7, 104; ≥46.8, 107]) men underwent measurement of carotid atherosclerosis.
†P<0.05; ‡P<0.01; §P<0.001.
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(MESA), current and former smoking were associated with
subclinical atherosclerosis at 3 anatomically distinct sites,
including CAC, CIMT, and ABI.5 A signiﬁcant relationship of
current or former smoking to CAC has also been previously
reported from other cohorts.4,30–32 Similarly, CIMT33–36 and
AoAC18 ﬁndings associated with smoking have been conﬁrmed
in previous studies. Our ﬁndings of CAC, CIMT, AoAC, and ABI
related to smoking in a Japanese population in addition to
these pieces of past evidence in the Western ones indicate that
both current and former smoking is strongly associated with
subclinical atherosclerosis in multiple vascular beds.
The present study revealed signiﬁcant dose-response
relationships between cumulative exposure and intensity of
smoking and carotid, aortic, and peripheral atherosclerosis in
both current and former smokers. MESA examined the
relationships, resulting in almost null associations of mea-
sures of subclinical atherosclerosis with pack-years smoking,
particularly in current smokers.5 This inconsistency between
studies may be explained by the fact that the relative impact
of cumulative smoking exposure for atherosclerosis was not
evaluated, compared to never smokers, in MESA.5 Another
reason for the discrepancy between studies may be because
of the difference in the study sample demographics, such as
smoking rate, pack-years exposure, and atherosclerotic
distribution. For example, cumulative pack-years exposure
among current smokers in the present study seems to be
higher than that in MESA.5 The higher pack-years exposure in
the present study could contribute to increased risks of
atherosclerosis among current smokers, particularly in the
highest group of pack-years. For the present study, signiﬁcant
dose–response relationships were not also conﬁrmed in the
associations particularly with CAC, although almost all ORs for
CAC among current smokers were statistically signiﬁcant
even in the lowest groups of cumulative exposure and
intensity, suggesting that cumulative exposure and intensity
of smoking may not be important, but current smoking
Table 3. Association of Smoking Cessation Interval With Subclinical Atherosclerosis in Carotid, Coronary, Aortic, and Peripheral
Vascular Beds in 1019 Men Aged 40 to 79 Years (SESSA, Shiga, Japan, 2006–2008)
Current (n=329)
Cessation Interval in Former Smokers
Never (n=181) P for Trend<10.4 Years (n=169) 10.4 to 24.3 Years (n=170) ≥24.4 Years (n=170)
CIMT >1.0 mm, n (%)* 45 (14.3) 32 (19.4) 40 (24.0) 33 (19.9) 22 (12.6)
OR 1 (Ref) 1.10 (0.63–1.91) 1.23 (0.72–2.10) 0.81 (0.46–1.41) 0.53 (0.29–0.98)† 0.013
Carotid plaque,
median (25th, 75th)*
2 (0, 4) 2 (1, 4) 2 (1, 4) 2 (1, 4) 2 (0, 3)
Ratio of expected
counts
1 (Ref) 1.08 (0.92–1.27) 0.89 (0.75–1.05) 0.81 (0.68–0.96)† 0.71 (0.59–0.84)§ <0.001
CAC >0, n (%) 211 (64.1) 112 (66.3) 108 (63.5) 112 (65.9) 108 (59.7)
OR 1 (Ref) 0.84 (0.53–1.32) 0.54 (0.34–0.86)‡ 0.52 (0.33–0.82)‡ 0.55 (0.35–0.85)‡ 0.005
CAC ≥100, n (%) 81 (24.6) 40 (23.7) 42 (24.7) 42 (24.7) 34 (18.8)
OR 1 (Ref) 0.71 (0.44–1.17) 0.65 (0.40–1.06) 0.58 (0.35–0.95)† 0.48 (0.29–0.81)‡ 0.008
CAC ≥400, n (%) 36 (10.9) 15 (8.9) 21 (12.4) 10 (5.9) 11 (6.1)
OR 1 (Ref) 0.59 (0.29–1.18) 0.80 (0.42–1.52) 0.29 (0.13–0.66)‡ 0.37 (0.17–0.82)† 0.008
ABI <1.1, n (%) 120 (36.5) 63 (37.3) 54 (31.8) 49 (28.8) 45 (24.9)
OR 1 (Ref) 0.99 (0.66–1.48) 0.71 (0.47–1.08) 0.60 (0.39–0.93)† 0.55 (0.36–0.85)‡ 0.002
AoAC >0, n (%) 276 (83.9) 145 (85.8) 145 (85.3) 152 (89.4) 132 (72.9)
OR 1 (Ref) 1.05 (0.53–2.11) 0.48 (0.23–0.98)† 0.33 (0.16–0.67)‡ 0.21 (0.11–0.41)§ <0.001
AoAC ≥100, n (%) 217 (66.0) 119 (70.4) 119 (70.0) 110 (64.7) 98 (54.1)
OR 1 (Ref) 0.97 (0.56–1.67) 0.55 (0.32–0.95)† 0.25 (0.15–0.43)§ 0.26 (0.16–0.44)§ <0.001
AoAC ≥1000, n (%) 103 (31.3) 57 (33.7) 69 (40.6) 45 (26.5) 30 (16.6)
OR 1 (Ref) 0.78 (0.48–1.26) 0.92 (0.57–1.48) 0.37 (0.22–0.61)§ 0.24 (0.14–0.42)§ <0.001
The reference category is current smokers. Cessation interval groups were categorized according to tertiles of years since smoking cessation. All values are expressed as ORs and ratios of
expected counts with 95% CIs. For dichotomous outcomes, logistic regression was used. For carotid plaque, negative binomial regression was used. Adjusted covariates included age, body
mass index, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, medication for hypertension and dyslipidemia (yes/no), diabetes mellitus (yes/no), alcohol
intake (g/week), exercise (yes/no), and C-reactive protein. The CT type was further included concomitantly when CAC and AoAC were analyzed. ABI indicates ankle-brachial index; AoAC,
aorta artery calciﬁcation; CAC, coronary artery calciﬁcation; CIMT, carotid intima-media thickness; OR, odds ratio; SESSA, Shiga Epidemiological Study of Subclinical Atherosclerosis.
*A total of 987 (current, 315; former, 498 [cessation interval <10.4 years, 165; 10.4–24.3 years, 167; ≥24.4 years, 166]; never, 174) men underwent measurement of carotid
atherosclerosis.
†P<0.05; ‡P<0.01; §P<0.001.
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behavior itself may be harmful for coronary atherosclerosis.
To our knowledge, only 2 studies, including our study,5 have
investigated the dose-response relationship with cumulative
pack-years exposure for atherosclerosis, including CAC,
whereas, according to another MESA report,37 cumulative
pack-years among current smokers was an important deter-
minant of CVD. Therefore, further research is necessary to
conﬁrm these associations in other populations and identify
mechanisms underlying these inconsistencies among studies.
The present study is one of the ﬁrst to comprehensively
reveal the association between smoking cessation and
subclinical atherosclerosis, including all 4 vascular beds.
The associations of smoking with CAC, CIMT, and ABI
decreased with time since quitting in former smokers in
MESA.5 A similar result between smoking cessation and CAC
was also observed in a German population-based study.4
Given that the present study is cross-sectional, our ﬁndings of
lower odds for subclinical atherosclerosis with longer time
since quitting do not represent that these risks are decreasing
over time in former smokers, rather that the accumulation of
these markers slows down after smoking cessation. Thus, a
shorter interval from cessation and a higher pack-year total
could be associated with increased atherosclerotic burdens in
former smokers. Additionally, the present analyses, which
were performed on time since cessation, do not address how
long after quitting smoking cardiovascular health returns to
the state of never smokers. Importantly, however, we extend
the past knowledge by demonstrating linear reductions on
atherosclerotic burdens in all 4 vascular beds with length of
time since smoking cessation, even though with some
differences among vascular sites and with slight attenuation
after further adjusting for amount of smoking.
Our study has several limitations. The study design was
cross-sectional. Therefore, causal and longitudinal relation-
ships were not addressed. However, cumulative pack-years
exposure and time since cessation themselves provide
information in the past to present; thus, these time frames
would support the causality. Also, smoking parameters were
based on self-report, rather than an objective marker, such as
cotinine, which could lead to the underestimation of the true
associations. Third, although we carefully controlled for the
major known confounders, our ﬁndings may, in part, be
explained by differences in unknown confounders. Finally,
because only Japanese men were included for analyses, our
results are restricted to men of a single ethnic group.
However, population homogeneity reduces possible confound-
ing from cultural and environmental variation.
In conclusion, in a community-based sample of Japanese
men without clinical CVD, the present study demonstrated
strong associations with subclinical atherosclerosis in multi-
ple vascular beds among both current and former smokers,
with dose-dependent relationships with cumulative exposure
or intensity. These harmful associations also attenuated with
time since smoking cessation. The subclinical atherosclerosis
in carotid, coronary, aortic, and peripheral arteries are all
strong predictors for CVD.38–41 Therefore, the new ﬁndings in
Japanese men, with high rates of smoking and smoking
cessation, support evidence for the negative impact of smoking
and beneﬁt for CVD prevention by smoking cessation as early
as possible and provide important implications for the tobacco
regulatory science on cardiovascular health worldwide.
Appendix
Members of the SESSA Research Group
Chairperson: Hirotsugu Ueshima (Center for Epidemiologic
Research in Asia, Department of Public Health, Shiga
University of Medical Science, Otsu, Shiga).
Co-chairpersons: Katsuyuki Miura (Department of Public
Health, Shiga University of Medical Science, Otsu, Shiga).
Research members: Minoru Horie, Yasutaka Nakano,
Takashi Yamamoto (Department of Cardiovascular and
Respiratory Medicine, Shiga University of Medical Science,
Otsu, Shiga), Emiko Ogawa (Health Administration Center,
Shiga University of Medical Science, Otsu, Shiga), Hiroshi
Maegawa, Itsuko Miyazawa (Division of Endocrinology and
Metabolism, Department of Medicine, Shiga University of
Medical Science, Otsu, Shiga), Kiyoshi Murata (Department
of Radiology, Shiga University of Medical Science, Otsu,
Shiga), Kenichi Mitsunami (Shiga University of Medical
Science, Otsu, Shiga), Kazuhiko Nozaki (Department of
Neurosurgery, Shiga University of Medical Science, Otsu,
Shiga), Akihiko Shiino (Biomedical MR Science Center, Shiga
University of Medical Science, Otsu, Shiga), Isao Araki
(Kusatsu Public Health Center, Kusatsu, Shiga), Teruhiko
Tsuru (Department of Urology, Shiga University of Medical
Science, Otsu, Shiga), Ikuo Toyama (Unit for Neuropathology
and Diagnostics, Molecular Neuroscience Research Center,
Shiga University of Medical Science, Otsu, Shiga), Hisakazu
Ogita, Souichi Kurita (Division of Medical Biochemistry,
Department of Biochemistry and Molecular Biology, Shiga
University of Medical Science, Otsu, Shiga), Toshinaga
Maeda (Central Research Laboratory, Shiga University of
Medical Science, Otsu, Shiga), Naomi Miyamatsu (Depart-
ment of Clinical Nursing Science Lecture, Shiga University of
Medical Science, Otsu, Shiga), Toru Kita (Kobe City Medical
Center General Hospital, Kobe, Hyogo), Takeshi Kimura
(Department of Cardiovascular Medicine, Kyoto University,
Kyoto), Yoshihiko Nishio (Department of Diabetes, Metabo-
lism, and Endocrinology, Kagoshima University, Kagoshima),
Yasuyuki Nakamura (Department of Food Science and
Human Nutrition, Faculty of Agriculture, Ryukoku University,
Otsu, Shiga), Tomonori Okamura (Department of Preventive
DOI: 10.1161/JAHA.116.003738 Journal of the American Heart Association 7
Smoking, Smoking Cessation and Atherosclerosis Hisamatsu et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on D
ecem
ber 27, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
Medicine and Public Health, School of Medicine, Keio
University, Tokyo), Akira Sekikawa, Emma J.M. Barinas-
Mitchell (Department of Epidemiology, Graduate School of
Public Health, University of Pittsburgh, Pittsburgh, PA, USA),
Daniel Edmundowicz (Department of Medicine, Section of
Cardiology, School of Medicine, Temple University, Philadel-
phia, PA, USA), Takayoshi Ohkubo (Department of Hygiene
and Public Health, Teikyo University School of Medicine,
Tokyo), Atsushi Hozawa (Preventive Medicine, Epidemiology
Section, Tohoku University, Tohoku Medical Megabank
Organization, Sendai, Miyagi), Nagako Okuda (Department
of Health and Nutrition, University of Human Arts and
Sciences, Saitama), Aya Higashiyama (Research and Devel-
opment Initiative Center, National Cerebral and Cardiovas-
cular Center, Suita, Osaka), Shinya Nagasawa (Department
of Epidemiology and Public Health, Kanazawa Medical
University, Kanazawa, Ishikawa), Yoshikuni Kita (Faculty of
Nursing Science, Tsuruga Nursing University, Tsuruga, Fukui),
Yoshitaka Murakami (Division of Medical Statistics, Depart-
ment of Social Medicine, Toho University, Tokyo), Aya
Kadota (Center for Epidemiologic Research in Asia, Depart-
ment of Public Health, Shiga University of Medical Science,
Otsu, Shiga), Akira Fujiyoshi, Naoyuki Takashima, Takashi
Kadowaki, Sayaka Kadowaki (Department of Public Health,
Shiga University of Medical Science, Otsu, Shiga), Robert D.
Abbott, Seiko Ohno (Center for Epidemiologic Research in
Asia, Shiga University of Medical Science, Otsu, Shiga),
Hisatomi Arima (Department of Preventive Medicine and
Public Health, Faculty of Medicine, Fukuoka University,
Fukuoka), Takashi Hisamatsu (Department of Environmental
Medicine and Public Health, Faculty of Medicine, Shimane
University, Izumo, Shimane), Naoko Miyagawa, Keiko Kondo,
Sayuki Torii, Yoshino Saito, Maryam Zaid, Sentaro Suzuki,
Takahiro Ito, Masahiro Yamazoe, Takeshi Shibukawa, and
Masaki Sumi (Department of Public Health, Shiga University
of Medical Science, Otsu, Shiga).
Acknowledgments
The authors are deeply indebted to staff members of the SESSA.
Sources of Funding
This research was supported by Grants-in-Aid for Scientiﬁc
Research (A) 13307016, (A) 17209023, (A) 21249043, (A)
23249036, and (A) 25253046 from the Ministry of Education,
Culture, Sports, Science and Technology Japan; and by
GlaxoSmithKlein.
Disclosures
None.
References
1. World Health Organization. Tobacco. 2016. Available at: http://
www.who.int/mediacentre/factsheets/fs339/en/. Accessed June 20, 2016.
2. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and
cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731–1737.
3. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB,
Fiore MC, Stein JH. Effects of smoking and smoking cessation on endothelial
function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol.
2010;55:1988–1995.
4. Jockel KH, Lehmann N, Jaeger BR, Moebus S, Mohlenkamp S, Schmermund A,
Dragano N, Stang A, Gronemeyer D, Seibel R, Mann K, Volbracht L, Siegrist J,
Erbel R. Smoking cessation and subclinical atherosclerosis–results from the
Heinz Nixdorf Recall Study. Atherosclerosis. 2009;203:221–227.
5. McEvoy JW, Nasir K, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, Barr RG,
Budoff MJ, Szklo M, Navas-Acien A, Polak JF, Blumenthal RS, Post WS, Blaha
MJ. Relationship of cigarette smoking with inﬂammation and subclinical
vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arterioscler
Thromb Vasc Biol. 2015;35:1002–1010.
6. Sekikawa A, Curb JD, Ueshima H, El-Saed A, Kadowaki T, Abbott RD, Evans RW,
Rodriguez BL, Okamura T, Sutton-Tyrrell K, Nakamura Y, Masaki K,
Edmundowicz D, Kashiwagi A, Willcox BJ, Takamiya T, Mitsunami K, Seto TB,
Murata K, White RL, Kuller LH; ERA JUMP Study Group. Marine-derived n-3
fatty acids and atherosclerosis in Japanese, Japanese-American, and white
men: a cross-sectional study. J Am Coll Cardiol. 2008;52:417–424.
7. Sekikawa A, Miura K, Lee S, Fujiyoshi A, Edmundowicz D, Kadowaki T, Evans
RW, Kadowaki S, Sutton-Tyrrell K, Okamura T, Bertolet M, Masaki KH,
Nakamura Y, Barinas-Mitchell EJ, Willcox BJ, Kadota A, Seto TB, Maegawa H,
Kuller LH, Ueshima H; ERA JUMP Study Group. Long chain n-3 polyunsaturated
fatty acids and incidence rate of coronary artery calciﬁcation in Japanese men
in Japan and white men in the USA: population based prospective cohort
study. Heart. 2014;100:569–573.
8. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M,
Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular
disease and risk factors in Asia: a selected review. Circulation.
2008;118:2702–2709.
9. Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Kadota A, Kadowaki S, Kadowaki
T, Yamamoto T, Miyagawa N, Zaid M, Torii S, Takashima N, Murakami Y,
Okamura T, Horie M, Ueshima H; SESSA Research Group. Lipoprotein particle
proﬁles compared with standard lipids in association with coronary artery
calciﬁcation in the general Japanese population. Atherosclerosis.
2014;236:237–243.
10. Kadota A, Miura K, Okamura T, Fujiyoshi A, Ohkubo T, Kadowaki T, Takashima
N, Hisamatsu T, Nakamura Y, Kasagi F, Maegawa H, Kashiwagi A, Ueshima H;
SESSA Research Group and NIPPON DATA Research Group. Carotid intima-
media thickness and plaque in apparently healthy Japanese individuals with an
estimated 10-year absolute risk of CAD death according to the Japan
Atherosclerosis Society (JAS) guidelines 2012: the Shiga Epidemiological
Study of Subclinical Atherosclerosis (SESSA). J Atheroscler Thromb.
2013;20:755–766.
11. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa H, Ito H, Tominaga M,
Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M,
Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M,
Yamakado M, Yatomi Y, Ohashi H; Committee on the Standardization of
Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society.
International clinical harmonization of glycated hemoglobin in Japan from
Japan Diabetes Society to National Glycohemoglobin Standardization Program
values. J Diabetes Investig. 2012;3:39–40.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of
low-density lipoprotein cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin Chem. 1972;18:499–502.
13. Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE. Physical activity and
coronary heart disease in women: is “no pain, no gain” passe? JAMA.
2001;285:1447–1454.
14. Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular
disease risk in women: review and meta-analysis. Am J Prev Med.
2004;26:407–418.
15. Torii S, Arima H, Ohkubo T, Fujiyoshi A, Kadota A, Takashima N, Kadowaki S,
Hisamatsu T, Saito Y, Miyagawa N, Zaid M, Murakami Y, Abbott RD, Horie M,
Miura K, Ueshima H; SESSA Research Group. Association between pulse wave
velocity and coronary artery calciﬁcation in Japanese men. J Atheroscler
Thromb. 2015;22:1266–1277.
16. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R.
Quantiﬁcation of coronary artery calcium using ultrafast computed tomogra-
phy. J Am Coll Cardiol. 1990;15:827–832.
17. Sekikawa A, Curb JD, Edmundowicz D, Okamura T, Choo J, Fujiyoshi A, Masaki
K, Miura K, Kuller LH, Shin C, Ueshima H. Coronary artery calciﬁcation by
DOI: 10.1161/JAHA.116.003738 Journal of the American Heart Association 8
Smoking, Smoking Cessation and Atherosclerosis Hisamatsu et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on D
ecem
ber 27, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
computed tomography in epidemiologic research and cardiovascular disease
prevention. J Epidemiol. 2012;22:188–198.
18. El-Saed A, Curb JD, Kadowaki T, Okamura T, Sutton-Tyrrell K, Masaki K, Seto
TB, Takamiya T, Choo J, Edmundowicz D, Evans RW, Fujiyoshi A, Nakamura Y,
Miura K, Shin C, Kuller LH, Ueshima H, Sekikawa A. The prevalence of aortic
calciﬁcation in Japanese compared to white and Japanese-American middle-
aged men is confounded by the amount of cigarette smoking. Int J Cardiol.
2013;167:134–139.
19. Mao SS, Pal RS, McKay CR, Gao YG, Gopal A, Ahmadi N, Child J, Carson S,
Takasu J, Sarlak B, Bechmann D, Budoff MJ. Comparison of coronary artery
calcium scores between electron beam computed tomography and 64-
multidetector computed tomographic scanner. J Comput Assist Tomogr.
2009;33:175–178.
20. Budoff MJ, Katz R, Wong ND, Nasir K, Mao SS, Takasu J, Kronmal R, Detrano
RC, Shavelle DM, Blumenthal RS, O’Brien KD, Carr JJ. Effect of scanner type on
the reproducibility of extracoronary measures of calciﬁcation: the Multi-Ethnic
Study of Atherosclerosis. Acad Radiol. 2007;14:1043–1049.
21. Zaid M, Fujiyoshi A, Miura K, Abbott RD, Okamura T, Takashima N, Torii S,
Saito Y, Hisamatsu T, Miyagawa N, Ohkubo T, Kadota A, Sekikawa A, Maegawa
H, Nakamura Y, Mitsunami K, Ueshima H; SESSA Research Group. High-
density lipoprotein particle concentration and subclinical atherosclerosis of
the carotid arteries in Japanese men. Atherosclerosis. 2015;239:444–450.
22. Sutton-Tyrrell K, Wolfson SK Jr, Thompson T, Kelsey SF. Measurement
variability in duplex scan assessment of carotid atherosclerosis. Stroke.
1992;23:215–220.
23. Budoff MJ, Nasir K, McClelland RL, Detrano R, Wong N, Blumenthal RS, Kondos
G, Kronmal RA. Coronary calcium predicts events better with absolute calcium
scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of
Atherosclerosis). J Am Coll Cardiol. 2009;53:345–352.
24. Fujiyoshi A, Miura K, Ohkubo T, Kadowaki T, Kadowaki S, Zaid M, Hisamatsu T,
Sekikawa A, Budoff MJ, Liu K, Ueshima H; SESSA Research Group and MESA
Research Group. Cross-sectional comparison of coronary artery calcium
scores between Caucasian men in the United States and Japanese men in
Japan: the Multi-Ethnic Study of Atherosclerosis and the Shiga Epidemiological
Study of Subclinical Atherosclerosis. Am J Epidemiol. 2014;180:590–598.
25. Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M, Detrano R, Post
W, Wong ND. Risk factor differences for aortic versus coronary calciﬁed
atherosclerosis: the Multiethnic Study of Atherosclerosis. Arterioscler Thromb
Vasc Biol. 2010;30:2289–2296.
26. Agatisa PK, Matthews KA, Bromberger JT, Edmundowicz D, Chang YF, Sutton-
Tyrrell K. Coronary and aortic calciﬁcation in women with a history of major
depression. Arch Intern Med. 2005;165:1229–1236.
27. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E,
Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor
AJ, Weintraub WS, Wenger NK, Jacobs AK; American College of Cardiology
Foundation/American Heart Association. 2010 ACCF/AHA guideline for
assessment of cardiovascular risk in asymptomatic adults: executive sum-
mary: a report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines. Circulation.
2010;122:2748–2764.
28. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg
LX. Association of coronary heart disease incidence with carotid arterial wall
thickness and major risk factors: the Atherosclerosis Risk in Communities
(ARIC) Study, 1987–1993. Am J Epidemiol. 1997;146:483–494.
29. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald
CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G,
Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes
FG, Lee AJ, Price JF, d’Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb
JD, Masaki KH, Rodriguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G,
Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus
JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A,
Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J,
McDermott MM. Ankle brachial index combined with Framingham Risk Score
to predict cardiovascular events and mortality: a meta-analysis. JAMA.
2008;300:197–208.
30. LaMonte MJ, FitzGerald SJ, Church TS, Barlow CE, Radford NB, Levine BD,
Pippin JJ, Gibbons LW, Blair SN, Nichaman MZ. Coronary artery calcium score
and coronary heart disease events in a large cohort of asymptomatic men and
women. Am J Epidemiol. 2005;162:421–429.
31. Loria CM, Liu K, Lewis CE, Hulley SB, Sidney S, Schreiner PJ, Williams OD, Bild
DE, Detrano R. Early adult risk factor levels and subsequent coronary artery
calciﬁcation: the CARDIA Study. J Am Coll Cardiol. 2007;49:2013–2020.
32. Rasmussen T, Frestad D, Kober L, Pedersen JH, Thomsen LH, Dirksen A,
Kofoed KF. Development and progression of coronary artery calciﬁcation in
long-term smokers: adverse effects of continued smoking. J Am Coll Cardiol.
2013;62:255–257.
33. Richey Sharrett A, Coady SA, Folsom AR, Couper DJ, Heiss G; Study A.
Smoking and diabetes differ in their associations with subclinical atheroscle-
rosis and coronary heart disease-the ARIC Study. Atherosclerosis.
2004;172:143–149.
34. Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N,
Jarvisalo MJ, Uhari M, Jokinen E, Ronnemaa T, Akerblom HK, Viikari JS.
Cardiovascular risk factors in childhood and carotid artery intima-media
thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA.
2003;290:2277–2283.
35. Baldassarre D, Castelnuovo S, Frigerio B, Amato M, Werba JP, De Jong A,
Ravani AL, Tremoli E, Sirtori CR. Effects of timing and extent of smoking, type
of cigarettes, and concomitant risk factors on the association between
smoking and subclinical atherosclerosis. Stroke. 2009;40:1991–1998.
36. Howard G, Burke GL, Szklo M, Tell GS, Eckfeldt J, Evans G, Heiss G. Active and
passive smoking are associated with increased carotid wall thickness. The
Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;154:1277–
1282.
37. McEvoy JW, Blaha MJ, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, Min
JK, Shaw LJ, Lloyd-Jones DM, Barr RG, Budoff MJ, Blumenthal RS, Nasir K.
Cigarette smoking and cardiovascular events: role of inﬂammation and
subclinical atherosclerosis from the Multiethnic Study of Atherosclerosis.
Arterioscler Thromb Vasc Biol. 2015;35:700–709.
38. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S,
Szklo M, Bluemke DA, O’Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA.
Coronary calcium as a predictor of coronary events in four racial or ethnic
groups. N Engl J Med. 2008;358:1336–1345.
39. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr.
Carotid-artery intima and media thickness as a risk factor for myocardial
infarction and stroke in older adults. Cardiovascular Health Study Collabora-
tive Research Group. N Engl J Med. 1999;340:14–22.
40. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak
JF, Powe NR, Siscovick D. Ankle-arm index as a predictor of cardiovascular
disease and mortality in the Cardiovascular Health Study. The Cardiovas-
cular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19:538–545.
41. van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC.
Predictive value of noninvasive measures of atherosclerosis for incident
myocardial infarction: the Rotterdam Study. Circulation. 2004;109:
1089–1094.
DOI: 10.1161/JAHA.116.003738 Journal of the American Heart Association 9
Smoking, Smoking Cessation and Atherosclerosis Hisamatsu et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on D
ecem
ber 27, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
1 
 
SUPPLEMENTAL MATERIAL 
Table S1. Association of cumulative smoking exposure by pack-years with subclinical atherosclerosis in the carotid, coronary, aortic, and 
peripheral vascular beds in 509 former smokers (SESSA, Shiga, Japan, 2006–2008) 
 
Never 
 (n = 181) 
Pack-years in former smokers 
P for trend 
  <16.1 (n = 171) 16.1–36.2 (n = 169) ≥36.3 (n = 169) 
CIMT >1.0 mm, n (%)§ 22 (12.6) 20 (11.9) 40 (24.2) 45 (27.3)  
OR 1 (ref) 1.27 (0.63–2.54) 2.2 (1.18–4.10)* 2.28 (1.24–4.21)† 0.003 
Carotid plaque, median 
(25th, 75th)§ 
2 (0, 3) 1 (0, 3) 2 (1, 4) 3 (2, 5) 
 
 Ratio of expected counts 1 (ref) 1.02 (0.84–1.25) 1.31 (1.08–1.58)† 1.57 (1.30–1.88)‡ <0.001 
CAC >0, n (%) 108 (59.7) 96 (56.1) 110 (65.1) 126 (74.6) 
 
 OR 1 (ref) 1.00 (0.61–1.62) 1.07 (0.65–1.75) 1.37 (0.82–2.28) 0.175 
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CAC ≥100, n (%) 34 (18.8) 28 (16.4) 47 (27.8) 49 (29.0) 
 
 OR 1 (ref) 1.06 (0.58–1.94) 1.49 (0.85–2.60) 1.41 (0.82–2.44) 0.149 
CAC ≥400, n (%) 11 (6.1) 8 (4.7) 16 (9.5) 22 (13.0) 
 
 OR 1 (ref) 1.04 (0.39–2.82) 1.32 (0.56–3.11) 1.89 (0.83–4.30) 0.048 
ABI <1.1, n (%) 45 (24.9) 46 (26.9) 53 (31.4) 67 (39.6)  
OR 1 (ref) 1.15 (0.7–1.87) 1.26 (0.78–2.03) 1.76 (1.09–2.82)* 0.013 
AoAC >0, n (%) 132 (72.9) 134 (78.4) 146 (86.4) 162 (95.9) 
 
 OR 1 (ref) 1.84 (0.95–3.56) 2.36 (1.13–4.93)* 5.57 (2.16–14.39)‡ <0.001 
AoAC ≥100, n (%) 98 (54.1) 83 (48.5) 119 (70.4) 146 (86.4) 
 
 OR 1 (ref) 0.88 (0.52–1.49) 1.96 (1.12–3.46)* 4.44 (2.37–8.30)‡ <0.001 
AoAC ≥1000, n (%) 30 (16.6) 33 (19.3) 56 (33.1) 82 (48.5) 
 
 OR 1 (ref) 1.58 (0.85–2.95) 2.18 (1.21–3.92)† 4.38 (2.48–7.75)‡ <0.001 
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Pack-years groups were categorized according to tertiles of pack-years in former smokers. All abbreviations are shown in Table 2. All values are 
expressed as ORs and ratios of expected counts with 95% confidence intervals. For dichotomous outcomes, logistic regression was used. For 
carotid plaque, negative binomial regression was used. Adjusted covariates are shown in Table 2.  
*P <0.05; †P <0.01, ‡P <0.001. 
§987 (never, 174; former, 498 [pack-years <16.1, 168; 16.1–36.2, 165; ≥36.3, 165]) men underwent measurement of carotid atherosclerosis. 
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Table S2. Association of smoking intensity by daily cigarette consumption with subclinical atherosclerosis in the carotid, coronary, aortic, and 
peripheral vascular beds in 1019 men (SESSA, Shiga, Japan, 2006–2008) 
 
Never  
 (n = 
181) 
Daily cigarette consumption in former smokers   
 
Daily cigarette consumption in current smokers   
  <20 (n = 167) 20 (n = 194) ≥21 (n = 148) 
P for 
trend 
  <16 (n = 111) 16–20 (n= 123) ≥21 (n = 95) 
P for 
trend 
CIMT >1.0 mm, n (%)§ 22 (12.6) 34 (20.7) 40 (21.3) 31 (21.2)   15 (14.4) 15 (12.7) 15 (16.1)  
OR 1 (ref) 
1.64 
(0.87–3.11) 
2.18 
(1.17–4.06)* 
2.04 
(1.06–3.95)* 
0.019  
1.55 
(0.71–3.36) 
1.74 
(0.80–3.79) 
2.76 
(1.23–6.20)* 
0.016 
Carotid plaque, median 
(25th, 75th)§ 
2 (0, 3) 2 (1, 3) 2 (1, 4) 2 (1, 5) 
  
1 (0, 4) 2 (0, 4) 2 (1, 4) 
 
 Ratio of expected 
counts 
1 (ref) 
1.03 
(0.85–1.26) 
1.33 
(1.11–1.60)† 
1.57 
(1.29–1.90)‡ 
<0.001 
 
1.23 
(0.98–1.53) 
1.41 
(1.13–1.75)† 
1.67 
(1.33–2.09)‡ 
<0.001 
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CAC >0, n (%) 
108 
(59.7) 
108 (64.7) 121 (62.4) 103 (69.6) 
  
74 (66.7) 75 (61.0) 62 (65.3) 
 
 OR 1 (ref) 
1.03 
(0.62–1.71) 
1.04 
(0.65–1.68) 
1.38 
(0.82–2.31) 
0.335 
 
1.85 
(1.04–3.27)* 
1.65 
(0.96–2.84) 
1.98 
(1.09–3.59)* 
0.028 
CAC ≥100, n (%) 34 (18.8) 38 (22.8) 49 (25.3) 37 (25.0) 
  
31 (27.9) 27 (22.0) 23 (24.2) 
 
 OR 1 (ref) 
1.12 
(0.63–1.99) 
1.46 
(0.85–2.52) 
1.42 
(0.79–2.54) 
0.144 
 
2.18 
(1.17–4.08)* 
1.88 
(0.99–3.56) 
2.18 
(1.09–4.36)* 
0.103 
CAC ≥400, n (%) 11 (6.1) 10 (6.0) 20 (10.3) 16 (10.8) 
  
14 (12.6) 11 (8.9) 11 (11.6) 
 
 OR 1 (ref) 
0.88 
(0.34–2.25) 
1.71 
(0.75–3.93) 
1.84 
(0.77–4.39) 
0.055 
 
2.86 
(1.14–7.13)* 
2.21 
(0.84–5.82) 
2.99 
(1.11–8.09)* 
0.084 
ABI <1.1, n (%) 45 (24.9) 52 (31.1) 56 (28.9) 58 (39.2)   39 (35.1) 50 (40.7) 31 (32.6)  
OR 1 (ref) 1.20 1.19 1.83 0.032  1.60 2.20 1.57 0.025 
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(0.74–1.96) (0.75–1.91) (1.12–2.99)* (0.94–2.74) (1.31–3.70)† (0.88–2.80) 
AoAC >0, n (%) 
132 
(72.9) 
139 (83.2) 168 (86.6) 135 (91.2) 
  
92 (82.9) 103 (83.7) 81 (85.3) 
 
 OR 1 (ref) 
1.46 
(0.71–3.00) 
2.55 
(1.26–5.13)† 
5.05 
(2.18–11.67)‡ 
<0.001 
 
3.82 
(1.66–8.79)† 
4.15 
(1.93–8.90)‡ 
5.40 
(2.31–12.63)‡ 
<0.001 
AoAC ≥100, n (%) 98 (54.1) 103 (61.7) 129 (66.5) 116 (78.4) 
  
73 (65.8) 82 (66.7) 62 (65.3) 
 
 OR 1 (ref) 
0.95 
(0.55–1.66) 
1.69 
(0.99–2.89) 
4.44 
(2.36–8.34)‡ 
<0.001 
 
2.91 
(1.49–5.68)† 
4.27 
(2.25–8.10)‡ 
4.22 
(2.10–8.47)‡ 
<0.001 
AoAC ≥1000, n (%) 30 (16.6) 46 (27.5) 71 (36.6) 54 (36.5) 
  
34 (30.6) 42 (34.1) 27 (28.4) 
 
 OR 1 (ref) 
1.57 
(0.86–2.86) 
3.39 
(1.92–6.00)‡ 
3.31 
(1.80–6.07)‡ 
<0.001   
2.95 
(1.51–5.76)† 
6.04 
(3.08–11.83)‡ 
4.02 
(1.91–8.45)‡ 
<0.001 
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Groups were divided according to tertiles of daily cigarette consumption in each smoker. All abbreviations are shown in Table 2. All values are 
expressed as ORs and ratios of expected counts with 95% confidence intervals. For dichotomous outcomes, logistic regression was used. For 
carotid plaque, negative binomial regression was used. Adjusted covariates are shown in Table 2.  
*P <0.05; †P <0.01, ‡P <0.001. 
§987 (never, 174; former, 498 [daily cigarette consumption <20, 164; 20, 188; ≥21, 146]; current, 315 [daily cigarette consumption <16, 104; 
16–20, 118; ≥21, 93]) men underwent measurement of carotid atherosclerosis. 
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Table S3. Association of smoking cessation interval with subclinical atherosclerosis in carotid, coronary, aortic, and peripheral vascular beds in 
1019 men aged 40–79 years (SESSA, Shiga, Japan, 2006–2008) 
 Current 
(n = 329) 
Cessation interval in former smokers 
Never (n = 181) 
P for 
trend   
<10.4 years  
(n = 169) 
10.4–24.3 years  
(n = 170) 
≥24.4 years  
(n = 170) 
CIMT >1.0 mm, n (%)§ 45 (14.3) 32 (19.4) 40 (24.0) 33 (19.9) 22 (12.6)  
OR 1 (ref) 1.06 (0.61–1.86) 1.17 (0.68–2.02) 0.82 (0.47–1.43) 0.62 (0.31–1.24) 0.143 
Carotid plaque, median 
(25th, 75th)§ 
2 (0, 4) 2 (1, 4) 2 (1, 4) 2 (1, 4) 2 (0, 3)  
 Ratio of expected counts 1 (ref) 1.03 (0.88–1.21) 0.84 (0.71–0.99)* 0.82 (0.69–0.97)* 0.86 (0.72–1.05) 0.046 
CAC >0, n (%) 211 (64.1) 112 (66.3) 108 (63.5) 112 (65.9) 108 (59.7)  
 OR 1 (ref) 0.82 (0.52–1.29) 0.54 (0.34–0.85)† 0.53 (0.33–0.83)† 0.61 (0.36–1.04) 0.020 
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CAC ≥100, n (%) 81 (24.6) 40 (23.7) 42 (24.7) 42 (24.7) 34 (18.8)  
 OR 1 (ref) 0.71 (0.43–1.17) 0.65 (0.39–1.07) 0.58 (0.35–0.95)* 0.49 (0.27–0.88)* 0.012 
CAC ≥400, n (%) 36 (10.9) 15 (8.9) 21 (12.4) 10 (5.9) 11 (6.1)  
 OR 1 (ref) 0.58 (0.28–1.17) 0.78 (0.40–1.52) 0.29 (0.13–0.67)† 0.39 (0.16–0.97)* 0.016 
ABI <1.1, n (%) 120 (36.5) 63 (37.3) 54 (31.8) 49 (28.8) 45 (24.9)  
OR 1 (ref) 0.97 (0.65–1.45) 0.70 (0.46–1.06) 0.61 (0.40–0.94)* 0.62 (0.37–1.03) 0.016 
AoAC >0, n (%) 276 (83.9) 145 (85.8) 145 (85.3) 152 (89.4) 132 (72.9)  
 OR 1 (ref) 0.95 (0.47–1.94) 0.48 (0.23–0.99)* 0.37 (0.18–0.76)† 0.43 (0.19–0.97)* 0.017 
AoAC ≥100, n (%) 217 (66.0) 119 (70.4) 119 (70.0) 110 (64.7) 98 (54.1)  
 OR 1 (ref) 0.86 (0.49–1.50) 0.51 (0.29–0.88)* 0.27 (0.16–0.46)† 0.44 (0.23–0.82)* <0.001 
AoAC ≥1000, n (%) 103 (31.3) 57 (33.7) 69 (40.6) 45 (26.5) 30 (16.6)  
OR 1 (ref) 0.74 (0.45–1.22) 0.87 (0.54–1.42) 0.37 (0.23–0.62)‡ 0.29 (0.15–0.55)‡ <0.001 
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The reference category is current smokers. Cessation interval groups were categorized according to tertiles of years since smoking cessation. All 
abbreviations are shown in Table 2. All values are expressed as ORs and ratios of expected counts with 95% confidence intervals. The statistical 
analyses are shown in Table 2. Adjusted covariates included age, body mass index, systolic blood pressure, total cholesterol, high-density 
lipoprotein cholesterol, medication for hypertension and dyslipidemia (yes/no), diabetes mellitus (yes/no), alcohol intake (g/week), exercise 
(yes/no), C-reactive protein, and daily cigarette consumption (for current smokers, daily amount of smoking; for former smokers, daily amount 
of prior smoking). The CT type was further included concomitantly when CAC and AoAC were analyzed. 
*P <0.05; †P <0.01, ‡P <0.001. 
§987 (current, 315; former, 498 [cessation interval <10.4 years, 165; 10.4–24.3 years, 167; ≥24.4 years, 166]; never, 174) men underwent 
measurement of carotid atherosclerosis.  
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Table S4. Association of smoking cessation interval with subclinical atherosclerosis in the carotid, coronary, aortic, and peripheral vascular beds 
in 509 former smokers (SESSA, Shiga, Japan, 2006–2008) 
 Never   
(n = 181) 
Cessation interval in former smokers 
P for 
trend   
≥24.4 years  
(n = 170) 
10.4–24.3 years  
(n = 170) 
<10.4 years  
(n = 169) 
CIMT >1.0 mm, n (%)§ 22 (12.6) 33 (19.9) 40 (24.0) 32 (19.4)  
OR 1 (ref) 1.53 (0.81–2.90) 2.32 (1.24–4.34)† 2.08 (1.08–3.98)* 0.013 
Carotid plaque, median 
(25th, 75th)§ 
2 (0, 3) 2 (1, 4) 2 (1, 4) 2 (1, 4)  
 Ratio of expected counts 1 (ref) 1.14 (0.94–1.39) 1.25 (1.03–1.52)* 1.53 (1.26–1.85)‡ <0.001 
CAC >0, n (%) 108 (59.7) 112 (65.5) 108 (63.5) 112 (66.3)  
 OR 1 (ref) 0.94 (0.58–1.55) 0.99 (0.60–1.63) 1.53 (0.92–2.53) 0.005 
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CAC ≥100, n (%) 34 (18.8) 34 (18.8) 42 (24.7) 42 (24.7)  
 OR 1 (ref) 1.20 (0.69–2.10) 1.35 (0.77–2.36) 1.48 (0.83–2.62) 0.008 
CAC ≥400, n (%) 11 (6.1) 10 (5.9) 21 (12.4) 15 (8.9)  
 OR 1 (ref) 0.79 (0.31–2.04) 2.15 (0.94–4.91) 1.58 (0.65–3.79) 0.008 
ABI <1.1, n (%) 45 (24.9) 49 (28.8) 54 (31.8) 63 (37.3)  
OR 1 (ref) 1.09 (0.67–1.77) 1.29 (0.80–2.09) 1.80 (1.12–2.90)* 0.002 
AoAC >0, n (%) 132 (72.9) 152 (89.4) 145 (85.3) 145 (85.8)  
 OR 1 (ref) 1.51 (0.74–3.10) 2.23 (1.06–4.70)† 4.90 (2.27–10.59)‡ <0.001 
AoAC ≥100, n (%) 98 (54.1) 110 (64.7) 119 (70.0) 119 (70.4)  
 OR 1 (ref) 0.96 (0.56–1.63) 2.10 (1.18–3.72)† 3.69 (2.02–6.75)‡ <0.001 
AoAC ≥1000, n (%) 30 (16.6) 45 (26.5) 69 (40.6) 57 (33.7)  
OR 1 (ref) 1.51 (0.84–2.73) 3.77 (2.11–6.73)‡ 3.18 (1.75–5.77)‡ <0.001 
 by guest on D
ecem
ber 27, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
13 
 
The reference category is never smokers. Cessation interval groups were categorized according to tertiles of years since smoking cessation. All 
abbreviations are shown in Table 2. All values are expressed as ORs and ratios of expected counts with 95% confidence intervals. For 
dichotomous outcomes, logistic regression was used. For carotid plaque, negative binomial regression was used. Adjusted covariates are shown 
in Table 2. 
*P <0.05; †P <0.01, ‡P <0.001. 
§987 (never, 174; 498 [cessation interval ≥24.4 years, 166; 10.4–24.3 years, 167; <10.4 years, 165]) men underwent measurement of carotid 
atherosclerosis. 
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